Acceptable time shift (days) | | | | ± 7 | ± 7 | ± 7 | ± 14 | ± 60 |
Physician assessment | | | X | | | | X | X |
Research nurse assessment | X | X | | | | | X | X |
- Informed consent | X | | | | | | | |
- Eligibility assessment | X | X | X | | | | | |
- Follow-up by staff delivering treatment and providing information (several times weekly) | | | X | X | X | X | | |
- Clinical assessment | X | X | b | b | b | b | | X |
- Counselling on prevention | | | X | X | X | X | X | X |
Elastographya | | X | | | | | (X) | X |
Lab tests | | | | | | | | |
- Viral testing | X | | | | | | X | X |
Full blood count and transaminases | X | | | b | b | b | X | X |
HSCL-10 (mental health) | X | | | | | | X | X |
FAS (fatigue symptoms) | X | | | | | | X | X |
EQ-5D-5 L (quality of life) | X | | | | | | X | X |
Infection risk behaviour | X | | | | | | X | X |
Substance use patterns | X | | | | | | X | X |
HCV genotyping and viral load | X | | | | | | X | X |